Impact of TRPV3 on the development of allergic dermatitis as a dendritic cell modulator

Experimental Dermatology

Volumn 22, Issue 12, 2013, Pages 820-824

  Yamamoto Kasai, Erika ^a,b   Yasui, Kiyoshi ^b   Shichijo, Michitaka ^b   Sakata, Tsuneaki ^a,b   Yoshioka, Takeshi ^b  

^a KOBE UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Atopic dermatitis; Contact hypersensitivity; Dendritic cell; Thymic stromal lymphopoietin; Transient receptor potential vanilloid subfamily V member 3

Indexed keywords

HAPTEN; THYMIC STROMAL LYMPHOPOIETIN; VANILLOID RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLERGY; WILD TYPE;

ATOPIC DERMATITIS; CONTACT HYPERSENSITIVITY; DENDRITIC CELL; THYMIC STROMAL LYMPHOPOIETIN; TRANSIENT RECEPTOR POTENTIAL VANILLOID SUBFAMILY V MEMBER 3;

ANIMALS; CELL MOVEMENT; CELL SEPARATION; CYTOKINES; DENDRITIC CELLS; DERMATITIS; DERMATITIS, CONTACT; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HAPTENS; HYPERSENSITIVITY; INFLAMMATION; KERATINOCYTES; LYMPH NODES; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; PHENOTYPE; SKIN TEMPERATURE; TRPV CATION CHANNELS;

EID: 84888332336     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12273     Document Type: Article

References (30)

1. Ostberg J R, Patel R, Repasky E A et al. Cell Stress Chaperones 2000: 5: 458-461.
2. Hikita I, Yoshioka T, Mizoguchi T et al. J Dermatol Sci 2002: 30: 142-153.
3. Yoshioka T, Hikita I, Asakawa M et al. Immunology 2006: 118: 293-301.
4. Yoshioka T, Hikita I, Matsutani T et al. Immunology 2003: 108: 562-569.
5. Yoshioka T, Imura K, Hikita I et al. Immunology 2007: 121: 51-61.
6. Asakawa M, Yoshioka T, Matsutani T et al. J Invest Dermatol 2006: 126: 2664-2672.
7. Clapham D E. Nature 2003: 426: 517-524.
8. Xu H, Ramsey I S, Kotecha S A et al. Nature 2002: 418: 181-186.
9. Peier A M, Reeve A J, Andersson D A et al. Science 2002: 296: 2046-2049.
10. Smith G D, Gunthorpe M J, Kelsell R E et al. Nature 2002: 418: 186-190.
11. Moqrich A, Hwang S W, Earley T J et al. Science 2005: 307: 1648-1672.
12. Cheng X, Jin J, Hu L et al. Cell 2010: 141: 331-343.
13. Yamamoto-Kasai E, Imura K, Yasui K et al. J Invest Dermatol 2012: 132: 2109-2112.
14. Nilius B, Bíró T. Exp Dermatol 2013: 22: 447-452.
15. Soumelis V, Reche P A, Kanzler H et al. Nat Immunol 2002: 3: 673-680.
16. Ito T, Liu Y J, Arima K et al. Allergol Int 2012: 61: 35-43.
17. Macatonia S E, Knight S C, Edwards A J et al. J Exp Med 1987: 166: 1654-1667.
18. Kripke M L, Munn C G, Jeevan A et al. J Immunol 1990: 145: 2833-2838.
19. Valladeau J, Ravel O, Dezutter-Dambuyant C et al. Immunity 2000: 12: 71-81.
20. Puig-Kröger A, Sanz-Rodríguez F, Longo N et al. J Immunol 2000: 165: 4338-4345.
21. Cumberbatch M, Kimber I. Immunology 1995: 94: 31-35.
22. Cumberbatch M, Dearman R J, Kimber I et al. Immunology 1997: 92: 388-395.
23. Kabashima K, Sakata D, Nagamachi M et al. Nat Med 2003: 9: 744-749.
24. Bogiatzi S I, Fernandez I, Bichet J C et al. J Immunol 2007: 178: 3373-3377.
25. Sano Y, Masuda K, Tamagawa-Mineoka R et al. Clin Exp Immunol 2013: 171: 330-337.
26. Lin Z, Chen Q, Lee M et al. Am J Hum Genet 2012: 90: 558-564.
27. Sherkheli M A, Benecke H, Doerner J F et al. J Pharm Pharm Sci 2009: 12: 116-128.
28. Park C O, Noh S, Jin S et al. Exp Dermatol 2013: 22: 6-9.
29. Asakawa M, Yoshioka T, Hikita I et al. Exp Anim 2005: 54: 461-465.
30. Yoshioka T, Imura K, Asakawa M et al. J Invest Dermatol 2009: 129: 714-722.